Physician profile
Robert Gamotis
NPI 1235474248
$966.98
in general payments reported to CMS, 2019-2025
10 companies · $95.86 in 2025
The $95.86 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.37 · 2020: $302 · 2021: $352 · 2022: $11.83 · 2023: $11.90 · 2024: $182 · 2025: $95.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239 · Honoraria: $50.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.36 |
| Honoraria | $50.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $345.18 | 2020-2025 | Invisalign, Itero Element 5d Plus Lite |
| Straumann USA LLC | $260.00 | 2021 | |
| Ultradent Products INC | $113.89 | 2024 | |
| Biohorizons Implant Systems INC. | $77.91 | 2020 | |
| Zest Holdings, LLC | $61.92 | 2025 | |
| Benco Dental Supply Co. | $50.01 | 2024 | |
| Gc America INC. | $17.71 | 2024 | G-Aenial, Equia |
| Solventum Corporation | $16.16 | 2025 | 3m Scotchbond, Filtek |
| Elevate Oral Care | $12.37 | 2019 | |
| Voco America INC. | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Gamotis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.